Flexion Therapeutics (United States)
- Research works
- 21 ▼ 87% vs 2018-21
- Citations
- 267 13.0 per fractional work
- Top-10% rate
- 12.0% all institutions 10.0%
- Open access
- 61% world 40%
- International
- 20% world 18%
Not ranked overall: Flexion Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Flexion Therapeutics (United States) work in?
In all years, 81% of research at Flexion Therapeutics (United States) is in Health Sciences, 10% in Physical Sciences. Its largest fields are Medicine (80%), Engineering (7%), Pharmacology, Toxicology and Pharmaceutics (4%). It does 2.5× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences1781.2%
- Medicine1680.1%
- Veterinary00.8%
- Health Professions00.3%
- Physical Sciences210.4%
- Engineering17.2%
- Energy01.6%
- Chemistry01.5%
- Environmental Science00.1%
- Life Sciences28.3%
- Social Sciences00.1%
- Social Sciences00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Flexion Therapeutics (United States)?
Ranked on the quality score, Neil C. Bodick, Joelle Lufkin and Scott D. Kelley lead among researchers whose main affiliation is Flexion Therapeutics (United States).
- 1
Neil C. Bodick
United States · #1,023,372 worldwide 2.5k citations · 53 works
- 2
Joelle Lufkin
United States · #1,348,717 worldwide 1.3k citations · 33 works
- 3
Scott D. Kelley
United States · #1,598,879 worldwide 2.5k citations · 87 works
- 4
Prachi Mehra
United States · #2,654,722 worldwide 358 citations · 18 works
- 5
Amy Çinar
United States · #4,133,569 worldwide 459 citations · 31 works
Which keywords describe research at Flexion Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Regeneration, Osteoarthritis, Cartilage, Chondrocyte, Cardiovascular Risk, Cyclooxygenase-2 Inhibitors and Rheumatoid Arthritis.
- Freeform Optics
- Compound Eyes
- Pain Management
- Rheumatoid Arthritis
- Cyclooxygenase-2 Inhibitors
- Cardiovascular Risk
- Cartilage
- Regeneration
- Inflammation
- Osteoarthritis
- Chondrocyte
- Cancer
- Epidemiology
- Chronic Pain
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Inflammation8▲ 17×5 topics
- Regeneration6▲ 171×2 topics
- Osteoarthritis6▲ 225×2 topics
- Cartilage6▲ 597×1 topic
- Chondrocyte6▲ 597×1 topic
- Cardiovascular Risk3▲ 37×3 topics
- Cancer2▲ 5.2×1 topic
- Cyclooxygenase-2 Inhibitors2▲ 188×1 topic
- Epidemiology2▲ 1.76×7 topics
- Rheumatoid Arthritis1▲ 64×2 topics
- Chronic Pain1▲ 24×3 topics
- Pain Management1▲ 22×4 topics
- Biological Therapy1▲ 88×1 topic
- Compound Eyes1▲ 358×1 topic
- Disease-Modifying Antirheumatic Drugs1▲ 101×1 topic
- Freeform Optics1▲ 358×1 topic
Which research topics does Flexion Therapeutics (United States) publish most on?
By volume in 2022-now: Musculoskeletal pain and rehabilitation, Spine and Intervertebral Disc Pathology, Plant Toxicity and Pharmacological Properties and Shoulder Injury and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Musculoskeletal pain and rehabilitation Pharmacology 0 works
- 2 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 0 works
- 3 Plant Toxicity and Pharmacological Properties Molecular Biology 0 works
- 4 Shoulder Injury and Treatment Surgery 0 works
- 5 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
- 6 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
- 7 Shoulder and Clavicle Injuries Epidemiology 0 works
- 8 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
- 9 HIV Research and Treatment Virology 0 works
- 10 Immunotherapy and Immune Responses Immunology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Flexion Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 87% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Flexion Therapeutics (United States) as a percentage of every work published that year, 0.0000069% in 2024.
Fractional works of Flexion Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Burlington
- Spectral Sciences (United States)
- Arqule (United States)
- Nuance Communications (United States)
- UFA (United States)
- Visidyne (United States)
- Boston Fusion (United States)
- Marine Polymer Technologies (United States)
- LeMaitre Vascular (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Flexion Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.